Camillo Ribi

Chief physician, MD, Associated Professor

Centre Hospitalier Universitaire Vaudois

Switzerland

Research Interests

Explore related searches

Professors in Switzerland Professors in Immunology Immunology professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dr. Camillo Ribi is the Chief Physician and Associated Professor at the Centre Hospitalier Universitaire Vaudois in Switzerland. His research primarily focuses on mitochondrial dysfunction in autoimmune diseases, particularly systemic lupus erythematosus and its renal involvement. Dr. Ribi has published extensively on topics including the implications of COVID-19 on systemic lupus erythematosus and various autoimmune conditions, contributing to a deeper understanding of their pathophysiology. His ongoing work aims to improve clinical outcomes for patients with these complex disorders.

Articles (8)

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Francesco Grandoni

Lausanne University Hospital (CHUV)

SWITZERLAND

View details

Matteo Monti

Senior physician and Senior medical lecturer

Centre Hospitalier Universitaire Vaudois

SWITZERLAND

View details

Carlo Chizzolini

University of Geneva

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Camillo Ribi

Research Interests

Explore related searches

Contact this professor

About

Articles (8)

Lower circulating mitochondrial DNA and increased mitokines suggest significant mitochondrial dysfunction in systemic lupus erythematosus with renal involvement

Mitochondrial Dysfunction in Systemic Lupus Erythematosus with a Focus on Lupus Nephritis

Myositis manifesting as respiratory insufficiency with anti-RNA polymerase III antibodies: an unusual presentation of graft-versus-host disease

ITGAM rs1143679 Variant in Systemic Lupus Erythematosus Is Associated with Increased Serum Calcification Propensity

Behçet’s-like adverse event or inaugural Behçet’s disease after SARS-CoV-2 mRNA-1273 vaccination?

Variants Affecting the C-Terminal Tail of UNC93B1 Are Not a Common Risk Factor for Systemic Lupus Erythematosus

Autoimmune Hemolytic Anemia and Pulmonary Embolism: An Association to Consider

Impact of COVID-19 pandemic on SLE: beyond the risk of infection

Collaborators (3)

Francesco Grandoni

Matteo Monti

Carlo Chizzolini

Make your next move.